GUERBET |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.05 EUR | +1.07% |
|
-1.64% | +69.49% |
| Apr. 09 | Guerbet: CE certificate for a platform | CF |
| Apr. 09 | Intrasense: awarded CE certificate | CF |
Business Summary
- X-ray imaging products (55.4%);
- MRI products (32.7%);
- other (11.9%): contrast products for echography and nuclear medicine, fine chemicals products.
At the end of 2023 the group had 8 production sites located in France (4), the United States (2), Ireland and Brazil.
Europe accounts for 39.7% of net sales.
Number of employees: 2,839
Sales per Business
| EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
X-Rays
55.4
%
| 415 | 55.1 % | 435 | 55.4 % | +4.87% |
Magnetic Resonance Imaging
32.7
%
| 248 | 32.9 % | 257 | 32.7 % | +3.67% |
Interventional Imaging
11.9
%
| 90 | 12.0 % | 93 | 11.9 % | +3.43% |
Sales per region
| EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Others
55.1
%
| 424 | 56.3 % | 433 | 55.1 % | +1.96% |
European Markets
44.9
%
| 329 | 43.7 % | 353 | 44.9 % | +7.32% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
David Hale
CEO | Chief Executive Officer | 55 | 18-01-31 |
Jérôme Estampes
DFI | Director of Finance/CFO | - | 19-03-31 |
| Chief Tech/Sci/R&D Officer | - | - | |
François Nicolas
CTO | Chief Tech/Sci/R&D Officer | 53 | 17-09-03 |
Dan Raffi
PRN | Corporate Officer/Principal | - | 23-07-09 |
Raoul Bernhardt
PRN | Corporate Officer/Principal | - | 23-07-09 |
| General Counsel | - | 10-12-31 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Thibault Viort
BRD | Director/Board Member | 51 | 17-05-18 |
Pascale Auger
BRD | Director/Board Member | 61 | 23-05-25 |
Mark Fouquet
BRD | Director/Board Member | 64 | 14-05-22 |
| Director/Board Member | 62 | 13-05-23 | |
Céline Lamort
BRD | Director/Board Member | 42 | 15-05-28 |
Nicolas Louvet
BRD | Director/Board Member | 47 | 16-05-26 |
Eric Guerbet
BRD | Director/Board Member | 47 | 17-05-18 |
Marc Massiot
BRD | Director/Board Member | 63 | 21-05-27 |
| Director/Board Member | - | - | |
Carine Dagommer
BRD | Director/Board Member | - | - |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 12,641,115 | 5,520,076 ( 43.67 %) | 18,671 ( 0.1477 %) | 43.67 % |
Holdings
| Name | Equities | % | Valuation |
|---|---|---|---|
GUERBET 0.17% | 21,143 | 0.17% | 750,111 $ |
Company contact information
Guerbet SA
15, rue des Vanesses Zone Paris Nord II
93420, Paris
+33 1 45 91 50 00
http://www.guerbet.com
Group companies
| Name | Category and Sector |
|---|---|
Packaged Software
| |
SA Guerbet NV
|
Sector
Sales per Business
Sales per region
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
33.05
EUR
Average target price
38.63
EUR
Spread / Average Target
+16.89%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +69.49% | 439M | |
| -10.31% | 13.91B | |
| -40.33% | 2.79B | |
| -20.66% | 2.21B | |
| -15.69% | 1.4B | |
| +42.39% | 540M | |
| +1.09% | 217M | |
| +1.11% | 183M | |
| -.--% | 167M | |
| -27.23% | 159M |
- Stock Market
- Equities
- GBT Stock
- Company Guerbet
